Instrument Inactif

Autres langues Pharmasset, Inc.

Actions

US71715N1063

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

2011

Wall Street finit en recul, crainte de récession mondiale

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Pharmasset, Inc. : Gilead Sciences Completes Acquisition of Pharmasset, Inc.	17/01/12
Pharmasset, Inc. : Gilead Sciences Completes Tender Offer for All Outstanding Shares of Pharmasset, Inc.	12/01/12
Pharmasset, Inc. : Pharmasset Announces Intent to Amend QUANTUM Trial	16/12/11
Pharmasset, Inc. : Ryan & Maniskas, LLP Announces Investigation of Pharmasset, Inc.	22/11/11
Pharmasset, Inc. : Pomerantz Law Firm Investigates Claims on Behalf of Investors of Pharmasset, Inc.	22/11/11
Pharmasset, Inc. : Gilead Sciences to Acquire Pharmasset, Inc. for $11 Billion	21/11/11
Pharmasset, Inc. : Pharmasset Reports Fiscal Year End 2011 Financial Results	14/11/11
Pharmasset, Inc. : Pharmasset to Present at the Lazard Capital Markets Healthcare Conference	14/11/11
Pharmasset, Inc. : Pharmasset to Present at Credit Suisse First Boston Healthcare Conference	08/11/11
Pharmasset, Inc. : Pharmasset to Webcast an Investor Event from the AASLD Meeting	04/11/11
Pharmasset, Inc. : Pharmasset Announces the Initiation of an Interferon-Free Phase 3 Program with PSI-7977 for HCV	01/11/11
Pharmasset, Inc. : Pharmasset Announces Further Expansion of ELECTRON Trial in Hepatitis C	10/10/11
PHARMASSE : Pharmasset to Present at Two Upcoming Conferences	16/09/11
PHARMASSE : Pharmasset Initiates QUANTUM, a Phase 2b Interferon-Free Trial of PSI-7977 and PSI-938 for All HCV Genotypes	13/09/11
PHARMASSE : Pharmasset Announces 91% SVR12 From the PROTON Trial in Subjects With Hepatitis C Genotype 1	06/09/11
PHARMASSE : Pharmasset to Present at Two Upcoming Conferences	06/09/11
PHARMASSE : PSI-938 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection	24/08/11
PHARMASSE : Pharmasset Announces Two-for-One Forward Stock Split	09/08/11
PHARMASSE : Pharmasset to Present at Canaccord Genuity Growth Conference	08/08/11
PHARMASSE : Pharmasset Reports Fiscal Third Quarter 2011 Financial Results	25/07/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Pharmasset, Inc.

Actions

US71715N1063

Autres langues

Filtres